Posted on April 19th, 2012, 9:56 am
![]() Mass High Tech | MarketWatch (press release) (NASDAQ:DYAX) and Eclipse Therapeutics, Inc., a privately held oncology company, announced today that Dyax has granted Eclipse an exclusive worldwide license for the development and commercialization of preclinical fully-human antibodies discovered ... |